Signal transduction pathways and transcriptional mechanisms of ABCB1/Pgp-mediated multiple drug resistance in human cancer cells
- PMID: 22613403
- DOI: 10.1177/147323001204000204
Signal transduction pathways and transcriptional mechanisms of ABCB1/Pgp-mediated multiple drug resistance in human cancer cells
Abstract
Multiple drug resistance (MDR), defined as the ability of tumour cells to survive exposure to many chemotherapeutic agents, is a major cause of treatment failure in human cancers. The membrane transporter P-glycoprotein (Pgp, encoded by the ABCB1 [adenosine triphosphate-binding cassette, subfamily B, member 1] gene) is the main mechanism for decreased intracellular drug accumulation in human MDR cancer. ABCB1/Pgp-mediated MDR involves several signal transduction pathways and transcription factors. Activation of these signal transduction pathways influences the prognosis of MDR human cancer. Signalling pathways involved in ABCB1/Pgp-mediated MDR include the mitogen-activated protein kinase (MAPK), c-Jun NH(2)-terminal kinase (JNK), p38, cyclic adenosine monophosphate-dependent protein kinase, phosphatidylino sitol 3-kinase and protein kinase C signalling pathways. This review summarizes the biological characteristics, target points and signalling cascade mediators of these pathways. Drugs targeted against these pathways may provide new therapies for treatment of ABCB1/Pgp-mediated MDR.
Similar articles
-
Down-regulation of intrinsic P-glycoprotein expression in multicellular prostate tumor spheroids by reactive oxygen species.J Biol Chem. 2001 May 18;276(20):17420-8. doi: 10.1074/jbc.M100141200. Epub 2001 Feb 20. J Biol Chem. 2001. PMID: 11279018
-
Afatinib reverses multidrug resistance in ovarian cancer via dually inhibiting ATP binding cassette subfamily B member 1.Oncotarget. 2015 Sep 22;6(28):26142-60. doi: 10.18632/oncotarget.4536. Oncotarget. 2015. PMID: 26317651 Free PMC article.
-
Down-regulation of the P-glycoprotein relevant for multidrug resistance by intracellular acidification through the crosstalk of MAPK signaling pathways.Int J Biochem Cell Biol. 2014 Sep;54:111-21. doi: 10.1016/j.biocel.2014.06.016. Epub 2014 Jul 17. Int J Biochem Cell Biol. 2014. PMID: 25043687
-
Redundancy of biological regulation as the basis of emergence of multidrug resistance.Int Rev Cytol. 2005;246:1-29. doi: 10.1016/S0074-7696(05)46001-5. Int Rev Cytol. 2005. PMID: 16164965 Review.
-
Transcriptional regulation of multidrug resistance in breast cancer.Breast Cancer Res Treat. 1994;31(2-3):263-71. doi: 10.1007/BF00666159. Breast Cancer Res Treat. 1994. PMID: 7881104 Review.
Cited by
-
Disrupting P-glycoprotein function in clinical settings: what can we learn from the fundamental aspects of this transporter?Am J Cancer Res. 2016 Aug 1;6(8):1583-98. eCollection 2016. Am J Cancer Res. 2016. PMID: 27648351 Free PMC article. Review.
-
Circular RNAs in Cancer: emerging functions in hallmarks, stemness, resistance and roles as potential biomarkers.Mol Cancer. 2019 Apr 18;18(1):90. doi: 10.1186/s12943-019-1002-6. Mol Cancer. 2019. PMID: 30999909 Free PMC article. Review.
-
Rhus verniciflua Stokes (RVS) and butein induce apoptosis of paclitaxel-resistant SKOV-3/PAX ovarian cancer cells through inhibition of AKT phosphorylation.BMC Complement Altern Med. 2016 Apr 27;16:122. doi: 10.1186/s12906-016-1103-3. BMC Complement Altern Med. 2016. PMID: 27121110 Free PMC article.
-
Dissecting the Role of Circular RNAs in Sarcomas with Emphasis on Osteosarcomas.Biomedicines. 2021 Nov 8;9(11):1642. doi: 10.3390/biomedicines9111642. Biomedicines. 2021. PMID: 34829872 Free PMC article. Review.
-
CRISPR/Cas9 gene editing: a new approach for overcoming drug resistance in cancer.Cell Mol Biol Lett. 2022 Jun 17;27(1):49. doi: 10.1186/s11658-022-00348-2. Cell Mol Biol Lett. 2022. PMID: 35715750 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
